Top Markets
Coin of the day
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204
Ранг среди акций #7949
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical... Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional chemical pharmaceuticals. The company's primary therapeutic areas address conditions related to the nervous system, infectious diseases, gastrointestinal health, the urinary system, and autoimmune disorders. Notably, Staidson has established a strategic partnership with Pivotal S.L. to conduct clinical trials in Europe for BDB-001, a monoclonal anti-C5a antibody, aimed at treating patients with severe, progressive COVID-19 caused by the SARS-CoV-2 virus. Founded in 2002, the company's headquarters are located in Beijing, China.
Цена акции
$3.11
Рыночная капитализация
$1.41B
Изменение (1 день)
-1.97%
Изменение (1 год)
-57.22%
Страна
CN
Торговля Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)

Категория

История дроблений акций Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)
Акции Staidson (Beijing) BioPharmaceuticals Co., Ltd. (символ: 300204) прошли через 0 дроблений.
Последнее дробление произошло Aug 28, 2026.
Одна акция 300204, купленная до Aug 28, 2026, сейчас соответствует 0 акциям 300204.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH